EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management

    September 2017 in “ Oncology and therapy
    Lauren Guggina, Andrew Choi, Jennifer N. Choi
    Image of study
    TLDR The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.
    Epidermal growth factor receptor inhibitors (EGFRIs), used for treating epithelial malignancies, are associated with dermatologic side effects due to their mechanism of action affecting skin, nails, and hair. The review from 2017 provides guidance on identifying and managing these side effects, which include papulopustular eruptions, nail changes, xerosis and pruritus, hair changes, mucositis, and exacerbated radiation dermatitis. While EGFRIs are generally better tolerated than traditional chemotherapy, their unique side-effect profile necessitates specific attention to cutaneous complications.
    Discuss this study in the Community →

    Cited in this study

    4 / 4 results

    Related

    7 / 7 results